/Investor DB

xista science ventures

Venture capital

Klosterneuburg · Pre-Seed–Series A · 11 people tracked

Find your way into xista science ventures

Sign up to see every warm intro you have to xista science ventures

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the xista science ventures team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

XISTA Science Ventures focuses on transforming cutting-edge science into viable companies, partnering with scientific founders at the earliest stages. Rooted in one of Europe's leading research ecosystems, the firm bridges academic discovery and real-world application across institutions and disciplines. It backs deep tech spin-offs in life sciences, digital technologies, and industrial innovation, providing not only capital but hands-on support, strategic guidance, access to networks, lab space, and infrastructure. The firm typically leads funding rounds and supports founders from round preparation through execution and beyond, viewing long-term success as a shared mission. It emphasizes helping academic researchers become entrepreneurs building sustainable, high-impact companies.

Source: firm website, verified Sep 27, 2026.

Stage
Pre-Seed–Series A
Check
$162K – $4.3M
HQ
Klosterneuburg, AT
Leads rounds
Leads
Instruments
Equity
Founded
2017
Last 12 months
4 investments
AUM
$103M
Tracked investments
26

Team · 11 people

from the firm's website & public directories
Erich Tauber· Venture Partner
Alexander Fischl· Core Team
Annu Gmeiner· Core Teamin
Melanie Leisser· Core Team
Sophia Hannes· Core Teamin
Stephan Huber· Core Team

What they invest in

from 18 of 26 portfolio companies

Deep Tech ×10AI & Machine Learning ×9Biotech ×9Healthtech ×5Medical Devices ×4Hardware ×3SaaS ×3Semiconductors ×2

HQs:Austria×5Germany×2France×1Slovenia×1United States×1

Who they back

founder profiles across 11 portfolio companies
27%
solo founders
3 of 11 mapped founding teams
13%
repeat founders
of 16 founders with career history

Founding team size:solo founder×32 founders×23 founders×34+ founders×3

Where their founders studiedfrom 15 founders with education data

Technische Universität Wien ×3Technical University of Munich ×2Universität für Weiterbildung Krems ×2

What their founders studiedfrom 16 founders with field-of-study data

Computer Science ×4Life Sciences ×3Business & Management ×2Chemistry ×2Engineering ×2Mathematics & Statistics ×2Physics ×2

Where their founders worked beforefrom 16 founders with career history

Fraunhofer IAO ×2Helmholtz Zentrum München ×2Medical University of Vienna ×2Technische Universität Wien ×2TUM Klinikum Rechts der Isar ×2

Investments · 26 tracked

founders shown can be your intro path

By year:2026 · 42024 · 12023 · 27 dated

Context Flowcontextflow.comin𝕏✓ verified

Contextflow develops AI-powered diagnostic software for chest CT analysis that detects and tracks pulmonary nodules, quantifies lung tissue disease patterns, and retrieves similar clinical cases to support radiologists in evaluating suspected lung cancer, interstitial lung disease, and COPD.

AI & Machine LearningDigital HealthHealthtechMedical DevicesVienna, AT

Georg Langs(Chief Scientist / Co-Founder)inAllan Hanbury(Big Data Evangelist / Co-Founder)inMarkus Holzer(CEO / Co-Founder)inRené Donner(Individual ML Contributor / Technical Advisor / Co-Founder)

Co-investorsAPEX VenturesNina CapitalB&C Innovation InvestmentsCrista Galli VenturesPeak PrideNovaCapital

Hephaistos-Pharmahephaistos-pharma.frinMay 2024✓ verified

HEPHAISTOS is a biopharmaceutical company developing third-generation innate immune boosters (TLR4 agonists) that convert myeloid-rich, immunotherapy-resistant tumors into immunotherapy-responsive tumors.

BiotechMedical DevicesOrsay, FR

Martine Caroff(Scientific Founder)inFrederic Caroff(CEO)inFrederique Brune(CDO)inStephan Braun(CMO)inJerome Kerzerho(CSO)inChristel Lonneux(CFO and HR)in

Co-investorsElaiaAngels SantéFemmes Business Angels

AVES Realityavesreality.cominJan 2026

AVES Reality converts real-world geographic data into simulation-ready 3D digital environments and HD maps for industrial applications.

AI & Machine LearningDeep TechDeveloper ToolsSaaSGarmisch-Partenkirchen, DE

Florian Albert(Co-founder)inSeverin Knebel(Co-founder)inMatthias Heger(Co-founder)in

Co-investorsBayern KapitalFraunhofer Tech Transfer FundMatterwave Ventures

CollimateHealthcollimatehealth.cominJun 2026 · $6.9M

CollimateHealth develops a clinically scalable microbeam radiation technology for cancer treatment, delivering arrays of narrow, micrometer-scale radiation beams at higher doses than conventional broad-beam radiation oncology.

BiotechHealthtechMedical Devices

Stefan Bartzsch(Co-founder & Chief Scientific Officer)inJohanna Winter(Co-founder & Chief Technology Officer)inHans Maria Heÿn(Co-founder & Chief Executive Officer)in

Co-investorsPositron VenturesCaesar VenturesHTGF

Constructorconstructor.comin𝕏Jun 2026

Constructor provides AI-powered product search and discovery software for ecommerce retailers.

AI & Machine LearningE-commerceRetail TechSaaSSan Francisco, US

Eli Finkelshteyn(Founder)inDan McCormick(Founder, former CTO at Shutterstock)inIgor Finkelshteyn(Executive Officer, Director)

BoardAsh Fontana(Director)in

Co-investorsFusionSapphire VenturesSignia Venture PartnersSilversmith Capital PartnersGreencode VenturesZetta Venture Partners

Cutanoscutanos.com

Cutanos is a biotechnology company developing a Langerhans Cell Targeted Delivery System (LC-TDS) that uses a langerin-specific glycomimetic ligand to direct lipid nanoparticle and mRNA/protein formulations to specific skin-resident dendritic cells for vaccines and immunotherapies.

BiotechDeep TechHealthtechVienna, AT

Christoph Rademacher(Co-Founder & Advisor)inRobert Wawrzinek(Co-Founder & Advisor (former CEO))Timm-H. Jessen(Interim CEO / Managing Director)Ulrich Platte(CFO & CBO)

Co-investorsKhanu

Epitome Therapeuticsepitome-tx.com

Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, an epigenome editing platform that controls gene expression without changing the DNA sequence.

BiotechDeep TechVienna, AT

Factorymakerfactorymaker.atin

AI-powered platform automating the design and optimization of industrial buildings.

Maria Antonia Zahlbruckner(Founder)in

Co-investors2bX

Infrared City GmbHinfrared.cityin𝕏

Infrared City builds an AI-powered platform for environmental and climate simulation, using machine learning and computational fluid dynamics to analyze the performance of buildings and urban spaces.

AI & Machine LearningClimate TechConstruction Tech

Angelos Chronis(CEO & Co-Founder)inOana Taut(CPO & Co-Founder)Theodoros Galanos(CSO & Co-Founder)Christos Chatzakis(CTO & Co-Founder)

Co-investors2bXAntlerHeartfelt CapitalKickstart Innovation

Neurolentechneurolentech.com

Neurolentech develops therapeutics for neurodevelopmental disorders such as epilepsy, intellectual disability, and severe autism, using patient-derived neuronal cell models to identify druggable targets and accelerate drug discovery.

AI & Machine LearningBiotechHealthtech

Ora Computingoracomputing.com

Ora Computing offers automated large language model compression using an information theory-based algorithm to shrink LLMs by up to 70% while preserving accuracy.

AI & Machine LearningCloud ComputingDeep Tech

Co-investorsConstructor Capital USGreencode Ventures

Prewaveprewave.cominMay 2023

Prewave provides supply chain risk management software that helps companies monitor suppliers for sustainability and resilience risks.

AI & Machine LearningEnterprise SoftwareLogistics & Supply ChainSaaS

Lisa Smith(Founder)inHarald Nitschinger(Founder)inLisa Madlberger(Founder)

Co-investorsaws GründungsfondsIsaiISAI GestionKOMPAS VCSeed+SpeedSpeedinvest+6 more

Recatalystrecatalyst.si

ReCatalyst develops a nanotechnology catalyst platform aimed at reducing dependency on scarce platinum group metals, starting with carbon-supported platinum-based catalysts for hydrogen technologies like fuel cells and water electrolysers.

CleantechDeep TechNew Materials

Co-investorsOCCIDENT

Ribbon Bioribbonbio.comin

Ribbon Bio develops cell-free DNA synthesis and analysis products for research and diagnostics applications.

BiotechDeep Tech

Dr. Wladimir Labeikovsky(Co-Founder, Head of Data Operations)

Co-investorsHadean VenturesLansdowne Partnerstecnet equity NÖ Technologiebeteiligungs-Invest GmbH

Sarcurasarcura.com

Sarcura is a company with a technical team focused on semiconductors, optical development, fluidics, electronics, and systems integration, indicating work in advanced manufacturing or hardware technology.

BiotechDeep TechHardwareMedical DevicesSemiconductors

Daniela Buchmayr(CEO)

Co-investorsHCVCNovaCapitalAME Cloud VenturesNina Capital

Solgate GmbHsolgate.com

Solgate is a drug discovery company developing small-molecule drugs that target solute carrier (SLC) membrane transporter proteins, using a platform combining chemical, biological, and computational technologies.

AI & Machine LearningBiotechDeep TechHealthtechKlosterneuburg, AT

Ariel Bensimon, PhD(Co-Founder & Chief Executive Officer)Stefan Kubicek, PhD(Co-Founder)Gaia Novarino, PhD(Co-Founder)Giulio Superti-Furga, PhD(Co-Founder)Georg Winter, PhD(Co-Founder)

Co-investorsWlanholding

Subdronsubdron.cominJul 2023

Subdron provides end-to-end autonomous underwater inspection solutions for critical subsea infrastructure, including port facilities, vessel hulls, and underwater cables.

Deep TechDefense TechHardwareIoTRobotics

Thomas(CEO)Arnau(CTO)

Co-investorsFaber

VALANXvalanx.bioin𝕏Mar 2026

VALANX Biotech develops a site-specific protein conjugation technology (GoldenSite) using click-chemistry to produce homogeneous antibody-drug conjugates with optimized conjugation sites.

AI & Machine LearningBiotech

Michael Lukesch(CEO & Founder)inGeorg Altenbacher(CBO & Co-Founder)inKlaus Orlinger(Chief Scientific Officer)in

Co-investorsSOSV

VitreaLabvitrealab.comin𝕏

Vitrealab develops and manufactures display components for augmented reality glasses using proprietary laser waveguide technology, produced in a dedicated cleanroom with custom fabrication processes.

Deep TechHardwareSemiconductorsVienna, AT

Co-investorsAPEX Venturesaws GründungsfondsConstructor Capital USExcellis HoldingGateway Trustee GmbHLIFTT+1 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AmplifoldBrainheroCellectricG.ST AntiviralsInvisible-Light LabsRivus BatteriesSyntropic Medical

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has xista science ventures made?
xista science ventures has 26 tracked investments, including 4 dated in the last 24 months.
What stage does xista science ventures invest at?
xista science ventures invests at the Pre-Seed, Seed, Series A stages.
What is xista science ventures's typical check size?
xista science ventures typically writes checks of $162K – $4.3M.
What sectors does xista science ventures focus on?
xista science ventures focuses on Advanced Manufacturing, AI & Machine Learning, Biotech, Cleantech, Climate Tech, Construction Tech, Deep Tech, Energy, Enterprise Software, Hardware, Healthtech, Medical Devices, New Materials, Robotics, SaaS.
Where is xista science ventures located?
xista science ventures is headquartered in Klosterneuburg, AT.
Does xista science ventures lead rounds?
Yes, xista science ventures leads investment rounds.
Who does xista science ventures co-invest with?
xista science ventures most often shares deals with aws Gründungsfonds, 2bX, APEX Ventures, among 35 tracked co-investors.

Similar investors

Featured in lists